Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials.
Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials.
复制标题
DOI:
10.1186/s12929-016-0289-5
复制
发表时间:
2016-11-04
影响因子:
11
通讯作者:
Yen BL
中科院分区:
文献类型:
--
作者:
Wang LT;Ting CH;Yen ML;Liu KJ;Sytwu HK;Wu KK;Yen BL
Human mesenchymal stem cells (MSCs) are multilineage somatic progenitor/stem cells that have been shown to possess immunomodulatory properties in recent years. Initially met with much skepticism, MSC immunomodulation has now been well reproduced across tissue sources and species to be clinically relevant. This has opened up the use of these versatile cells for application as 3rd party/allogeneic use in cell replacement/tissue regeneration, as well as for immune- and inflammation-mediated disease entities. Most surprisingly, use of MSCs for in immune-/inflammation-mediated diseases appears to yield more efficacy than for regenerative medicine, since engraftment of the exogenous cell does not appear necessary. In this review, we focus on this non-traditional clinical use of a tissue-specific stem cell, and highlight important findings and trends in this exciting area of stem cell therapy.
登录
查看更多内容
影响因子:
2.6
作者:
Bartholomew, A;Sturgeon, C;Hoffman, R
通讯作者:
Hoffman, R
影响因子:
5.2
作者:
Chang, Chun-Jung;Yen, Men-Luh;Yen, B. Linju
通讯作者:
Yen, B. Linju
影响因子:
4.4
作者:
Cutler, Antony J.;Limbani, Vasanti;Navarrete, Cristina V.
通讯作者:
Navarrete, Cristina V.
DOI:
10.1152/ajplung.00182.2009
发表时间:
2010-12-01
影响因子:
4.9
作者:
Bonfield, Tracey L.;Koloze, Mary;Caplan, Arnold I.
通讯作者:
Caplan, Arnold I.
影响因子:
5.2
作者:
Auletta, Jeffery J.;Eid, Saada K.;Wuttisarnwattana, Patiwet;Silva, Ines;Metheny, Leland;Keller, Matthew D.;Guardia-Wolff, Rocio;Liu, Chen;Wang, Fangjing;Bowen, Theodore;Lee, Zhenghong;Solchaga, Luis A.;Ganguly, Sudipto;Tyler, Megan;Wilson, David L.;Cooke, Kenneth R.
通讯作者:
Cooke, Kenneth R.